IRIS
CERULLO, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.577
NA - Nord America 1.298
AS - Asia 967
SA - Sud America 143
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.027
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.250
RU - Federazione Russa 786
SG - Singapore 470
IT - Italia 338
HK - Hong Kong 225
CN - Cina 158
BR - Brasile 130
FR - Francia 92
DE - Germania 91
NL - Olanda 79
IN - India 59
FI - Finlandia 52
CA - Canada 39
GB - Regno Unito 33
UA - Ucraina 32
IE - Irlanda 22
CI - Costa d'Avorio 19
SE - Svezia 19
VN - Vietnam 14
ZA - Sudafrica 14
AT - Austria 9
KR - Corea 9
ES - Italia 7
BD - Bangladesh 6
PL - Polonia 5
CZ - Repubblica Ceca 4
MX - Messico 4
PK - Pakistan 4
IQ - Iraq 3
JP - Giappone 3
LT - Lituania 3
MA - Marocco 3
PY - Paraguay 3
TR - Turchia 3
UZ - Uzbekistan 3
AR - Argentina 2
CL - Cile 2
IL - Israele 2
SA - Arabia Saudita 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BE - Belgio 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
EU - Europa 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 4.027
Salva come PNG Salva come JPEG
Città #
Singapore 314
Hong Kong 225
Moscow 221
Chandler 162
Santa Clara 133
Naples 95
Millbury 81
Ashburn 65
Amsterdam 61
Boston 43
Napoli 42
Delhi 38
Princeton 38
Nanjing 33
Des Moines 32
Lawrence 30
Munich 28
Ottawa 27
Seattle 24
Jacksonville 21
Wilmington 21
Nanchang 20
Rome 19
Hefei 18
Helsinki 17
Beijing 15
Shanghai 13
Dong Ket 12
Turku 12
Frankfurt am Main 11
Shenyang 11
Dallas 10
Hebei 10
Jiaxing 10
Kochi 10
Nuremberg 9
Houston 8
Bexley 7
Council Bluffs 7
Los Angeles 7
Seoul 7
Acerra 6
Kronberg 6
Lappeenranta 6
San Francisco 6
The Dalles 6
Toronto 6
Johannesburg 5
Porto Alegre 5
Pune 5
Roubaix 5
São Paulo 5
Florence 4
Lissone 4
New York 4
Phoenix 4
Salvador 4
Sesto Fiorentino 4
Vienna 4
Boardman 3
Brooklyn 3
Changsha 3
Columbus 3
Denver 3
Düsseldorf 3
Fairfield 3
Gravataí 3
London 3
Mexico City 3
Milan 3
Portici 3
Recife 3
Santiago de Compostela 3
Tashkent 3
Tianjin 3
Warsaw 3
Woodbridge 3
Ankara 2
Ann Arbor 2
Arzano 2
Asunción 2
Barbianello 2
Betim 2
Bologna 2
Bolzano 2
Bregnano 2
Brescia 2
Brindisi 2
Brno 2
Campinas 2
Carney 2
Casablanca 2
Caxias do Sul 2
Centro 2
Chennai 2
Chuncheon 2
Dhaka 2
Dublin 2
Ercolano 2
Florianópolis 2
Totale 2.156
Salva come PNG Salva come JPEG
Nome #
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 161
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 97
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy 96
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy. 94
Ischemic Neoangiogenesis Enhanced by {beta}2-Adrenergic Receptor Overexpression. A Novel Role for the Endothelial Adrenergic System. 91
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/ double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumour activity 90
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 82
Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice 76
PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice 75
AKT participates in endothelial dysfunction in hypertension. 74
Synthesis and Evaluation of the Antiproliferative Properties of a Tethered Tubercidin-Platinum(II) Complex 71
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 71
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 69
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies 68
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumor activity 66
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors 66
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 62
PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile 60
Solid phase synthesis of new dinuclear platinum complexes having a modified nucleoside as ligand. 60
Viral molecular mimicry influences the antitumor immune response in murine and human melanoma 60
Oncolytic adenoviruses for cancer therapy 59
Discovery of a new PCC-mediated stereoselective oxidative spiroketalization process. An access to a new type of poly-THF spiroketal compound displaying anticancer activity 58
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 58
Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system. 57
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses 56
Bioengineered Factor IX Molecules with Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. 55
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor 55
Application of array-comparative genomic hybridization analysis in immune-virotherapy approach 54
Artificially cloaked viral nanovaccine for cancer immunotherapy 53
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines 53
Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells 52
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery 52
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors 51
The evolution of adenoviral vectors through genetic and chemical surface modifications 51
Generation of a helper-dependent adenoviral vector by homologous recombination 50
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 50
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 50
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification 47
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma (vol 6, e1319028, 2017) 46
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 46
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors 45
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 45
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans 44
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients 43
Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver 43
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy 42
Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy 42
Toll-like Receptor 9 Triggers an Innate Immune Response to Helper-dependent Adenoviral Vectors. 41
Short-Term Correction of Arginase Deficiency in a Neonatal Murine Model with a Helper-Dependent Adenoviral Vector. 41
Chronic activation of innate immunity correlates with poor prognosis in cancer patients treated with oncolytic adenovirus 40
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus 40
Uncovering the tumor antigen landscape: What to know about the discovery process 39
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 39
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 37
MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to Helper-dependent adenovirus. 36
Design and application of oncolytic viruses for cancer immunotherapy 36
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site 35
Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy 35
Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus 34
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy 34
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin 34
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer 33
PNA-functionalized adenoviral vectors as new tool for gene modulation in anti-cancer treatment 33
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors 32
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance 32
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus 32
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice 32
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging 31
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction 31
Thiol-ene surface modifications for microchip electrophoresis based interaction assays 29
Immunological Effects of a Tumor Necrosis Factor Alpha-Armed Oncolytic Adenovirus 29
Pathogens: Our Allies against Cancer? 29
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy 28
Low-dose Decitabine enhances the efficacy of viral cancer vaccines for immunotherapy 28
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids 27
Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients 26
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo 26
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses 26
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform 26
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment 25
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus 25
GMCSF-armed vaccinia virus induces an antitumor immune response 24
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: Assessment of safety and immunologic responses in patients 21
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 21
Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions 21
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors 19
Totale 4.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.822
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.822
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 5 2 36 3 6 12 5 20 13 5 9 16
2021/2022348 6 0 0 7 1 11 3 12 48 11 78 171
2022/2023486 71 47 11 20 50 44 1 54 71 70 25 22
2023/2024407 31 76 52 19 15 36 19 58 3 4 61 33
2024/20252.320 135 122 10 15 66 122 247 147 143 280 845 188
2025/2026103 103 0 0 0 0 0 0 0 0 0 0 0
Totale 4.153